K-808
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for K-808, covering 2025-09-10 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment. [Phase 2]